Skip to Content
Chemistry ProceedingsChemistry Proceedings
  • Proceeding Paper
  • Open Access

16 October 2026

5 Pages

Harnessing Supramolecular Chemistry for Gene Therapy: Cyclodextrin-Based Platforms for Nucleic Acid Delivery †

,
,
,
,
,
,
,
,
…
1
Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy
2
Department of Life Sciences, University of Modena and Reggio Emilia, Via Giuseppe Campi 103, 41125 Modena, Italy
*
Author to whom correspondence should be addressed.
†
Presented at the 30th International Electronic Conference on Synthetic Organic Chemistry, 5–19 November 2026.

Abstract

At the interface between chemistry and medicine, supramolecular assemblies are emerging as versatile platforms for therapeutic delivery. Their reversible non-covalent interactions and chemically tunable architectures allow the design of adaptive systems capable of transporting not only conventional small molecules, but also fragile biological macromolecules. In this context, gene therapy emerges as a transformative approach for cancer, metabolic disorders, and rare diseases, enabling modulation or correction of defective genes and gene products. However, the clinical translation of therapeutic nucleic acids, including miRNAs, anti-miRNAs, and related oligonucleotides, remains limited by poor membrane permeability, high hydrophilicity, large size, and rapid enzymatic degradation, requiring safe, biocompatible, and non-viral delivery systems. β-Cyclodextrin (β-CD) represents a privileged supramolecular building block for this purpose. Its hydrophobic cavity, hydrophilic surface, and derivatizable hydroxyl groups enable complex architectures, including first-generation β-CD-based nanosponges (NSs). These crosslinked polymeric systems combine host–guest inclusion, porous macromolecular organization, and opportunities for functional modification. In our design, bridge-like molecules (BLMs) based on cationic adamantyl derivatives can act as supramolecular connectors, promoting simultaneous interaction with the β-CD cavity and the anionic phosphate backbone of therapeutic nucleic acids. These modular platforms provide a proof of concept for supramolecular assemblies supporting nucleic acid delivery. Conceived for topical ocular administration, they may guide further optimization toward local or systemic applications in next-generation gene therapy.

1. Introduction

In recent decades, advances in biotechnology have considerably broadened the range of therapeutic strategies available, particularly through the development of nucleic acid-based approaches alongside conventional small-molecule drugs. Therapeutic nucleic acids can modulate disease-associated genes and their products at the DNA or RNA level. However, their effective use still depends strongly on suitable delivery systems able to protect the cargo from degradation, promote cellular uptake, and preserve its biological activity [1,2,3]. These limitations are particularly relevant for miRNAs, anti-miRNAs, and siRNAs, whose hydrophilic and polyanionic nature strongly limits passive permeation across biological membranes.
Supramolecular chemistry offers a modular strategy to address these limitations. In supramolecular delivery systems, the nucleic acid cargo can be associated with the carrier through reversible non-covalent interactions rather than permanent covalent conjugation. This approach allows the carrier to protect and deliver the therapeutic cargo while facilitating its subsequent release without chemically modifying the nucleic acid itself, thereby minimizing the risk of interfering with its biological function.In this context, β-cyclodextrins (β-CDs) have been extensively investigated for pharmaceutical applications because of their ability to form inclusion complexes and to serve as building blocks for more complex delivery systems. Their peculiar architecture combines a relatively hydrophobic internal cavity, capable of accommodating suitable lipophilic guests, with a hydrophilic outer surface bearing multiple hydroxyl groups that can be readily functionalized. Crosslinking β-CD produces three-dimensional polymeric networks known as nanosponges (NSs), which retain the molecular-recognition properties of β-CDs while introducing the additional features of a crosslinked polymeric matrix [4,5,6].
The system can be further functionalized through guest molecules, taking advantage of the well-known affinity of the adamantyl moiety for the β-CD cavity. When combined with a cationic group, these molecules can act as bridge-like molecules (BLMs), associating with the β-CDs -based carrier while providing a positively charged component able to interact with the negatively charged phosphate backbone of nucleic acids.
This strategy has already been successfully explored in an ocular delivery platform based on NSs and an amphipathic cationic adamantane derivative (ADM). In that study, the system enabled the topical administration of a therapeutic anti-miRNA and provided an in vivo proof of concept in a mouse model of retinitis pigmentosa [7]. Starting from this established platform, the present work explores the effect of different β-CD ratios on the physicochemical properties of first-generation NSs and their subsequent supramolecular association with ADM.

2. Methods

2.1. Preparation of β-Cyclodextrin Nanosponges

NSs were prepared by carbonate crosslinking of β-CD with diphenyl carbonate (DPC), according to previously reported procedures [4,5,6,7]. β-CD molar ratios ranging from 1:1 to 1:16 were investigated to explore the influence of crosslinker content on the resulting NS systems. After synthesis, the materials were purified to remove unreacted reagents and low-molecular-weight by-products and dried before characterization.

2.2. Inclusion of the Adamantane Derivative

Among the investigated systems, the NS from the 1:8 ratio was selected for supramolecular functionalization with 2-(1-adamantyl)-N,N,N-triethylethan-1-aminium iodide (ADM). NSs and ADM were dispersed in an ethanol/water mixture and stirred at room temperature to obtain the corresponding supramolecular complex (NSC).

2.3. Spectroscopic and Colloidal Characterization

FTIR spectroscopy was used to characterize the β-CD-based systems and confirm formation of the carbonate-crosslinked network. Spectra were recorded using a VERTEX 70 FT-IR spectrophotometer (Bruker, Singapore) equipped with a deuterium triglycine sulfate (DTGS) detector and a Golden-Gate ATR accessory (PerkinElmer, Singapore). Spectra were acquired in the 4000–600 cm−1 range at a resolution of 4 cm−1, collecting 32 scans for each sample.
1H NMR spectroscopy provided complementary structural information and was also used to support the association between the NS and ADM. NMR spectra were recorded in DMSO-d6 on a Bruker 400 spectrometer (Bruker, Singapore) operating at 400 MHz.
Particle size and polydispersity index (PDI) were evaluated by dynamic light scattering (DLS). Samples were dispersed in Milli-Q water, sonicated before analysis, and measured in triplicate at 25 °C using a Malvern Zetasizer Nano ZS (Malvern Panalytical Ltd., Malvern, UK).

2.4. Supramolecular Assembly

ADM was associated with NSs to generate NSC. In this system, the adamantyl group provides the recognition element for the β-CD cavities, whereas the positively charged ammonium moiety introduces a cationic interface suitable for interaction with anionic nucleic acids.

3. Results and Discussion

3.1. Preparation and Characterization of β-Cyclodextrin Nanosponges

First-generation NSs were prepared by crosslinking β-CD with diphenyl carbonate (DPC). β-CD and DPC were mixed in the solid state and heated at 90 °C for 5 h, followed by purification with water and ethanol and vacuum drying. The influence of the crosslinking conditions was explored more broadly by preparing a series of NS with β-CD molar ratios of 1:1, 1:2, 1:4, 1:8, and 1:16. Thus, while the molar amount of β-CD was maintained as the reference component, progressively increasing amounts of DPC were used to modulate the extent of carbonate-mediated crosslinking and, consequently, the architecture of the resulting polymeric network.
Formation of the NS systems was first confirmed by FTIR spectroscopy. Compared with native β-CD, the NS spectra showed the characteristic modifications associated with the formation of the carbonate-crosslinked network, particularly in the carbonate C=O and carbohydrate C–O/C–O–C regions. These spectral changes confirmed that the β-CD framework was retained while being incorporated into the polymeric network.
Subsequent 1H NMR analysis provided complementary evidence of the system architecture. The peculiar β-CD proton resonances were retained after polymerization, with the anomeric protons appearing at approximately 5.06 ppm and the remaining sugar proton signals distributed between approximately 3.55 and 3.98 ppm. Comparison of the spectra of DPC, native β-CD, and NSs further supported the formation and purification of the crosslinked material.
The effect of the β-CD ratio on the colloidal behavior of the different preparations was then evaluated by DLS. Interestingly, native β-CD showed an apparent mean hydrodynamic size of 671.4 ± 55.6 nm, with a PDI of 0.447 ± 0.08, thereby showing aggregation/association in dispersion. Otherwise, crosslinking initially resulted in smaller dispersed systems, with NS 1:1 and NS 1:2 showing mean sizes of 554.0 ± 72.5 and 530.2 ± 73.0 nm, respectively, with corresponding PDI values of 0.379 ± 0.06 and 0.478 ± 0.06. Further increasing the amount of DPC did not produce a progressive reduction in size. In fact, intermediate NS 1:4 showed a mean diameter of 615.0 ± 39.4 nm (PDI 0.524 ± 0.05), while NS 1:8 reached 682.7 ± 99.9 nm (PDI 0.440 ± 0.08). Thus, across the 1:1–1:8 range, the systems remained broadly within the same submicrometric size range despite differences in crosslinker content.
A clear change in the trend was instead observed for the highest DPC ratio, with NS 1:16 displaying a mean hydrodynamic size of 1510 ± 120.1 nm, approximately twice that observed for NS 1:8, despite showing the lowest PDI of the series (0.328 ± 0.09). This is likely to correspond to the formation of larger supramolecular assemblies or aggregates in aqueous dispersion.
Overall, the DLS data show that the amount of DPC used during NS preparation has a clear but non-linear effect on colloidal behavior.

3.2. Supramolecular Association with the Adamantane Derivative

The selected NS 1:8 was subsequently combined with the amphipathic cationic adamantane derivative ADM (IUPAC: 2-(1-adamantyl)-N,N,N-triethylethan-1-aminium iodide). [7] This system is reported to be generated thanks to host–guest interactions, with the hydrophobic adamantyl moiety interacting with the β-CD cavities. Interestingly, within this configuration, the quaternary ammonium group is available for further interactions. NSC was obtained by combining the two components in a 1:1 ratio in an ethanol/water mixture under stirring at room temperature, as previously reported [7].
Interestingly, 1H NMR spectra analysis showed the characteristic signals of both NSs and ADM, but chemical shifts were affected, consistent with host–guest interaction between the adamantane moiety and the β-CD cavities [7].

4. Conclusions

This study expands the physicochemical characterization of first-generation β-CD-based NSs by assessing how the starting material ratio affects their colloidal properties. Interestingly, changes in the relative amount of DPC produced measurable differences in hydrodynamic size and dispersity, with a non-linear trend.
The subsequent association of the selected NS 1:8 with ADM further extends the versatility of this system. Host–guest interactions between the BLM and the β-CD cage provide a straightforward strategy for introducing a cationic component into the NS architecture without changing the β-CD polymeric scaffold. This modularity is particularly attractive for nucleic acid delivery, where interactions between the cationic supramolecular carrier and the negatively charged oligonucleotide can be exploited without direct covalent modification of the therapeutic cargo.
Notably, this platform has been explored and validated in vivo as a carrier for topical ocular delivery of anti-miR-155-5p in the rd10 mouse model of retinitis pigmentosa [7]. Specifically, the system was demonstrated to deliver the therapeutic nucleic acid and produce its associated functional effects, providing a relevant proof of concept for the NS/BLM-based strategy.
These findings support further investigation of NS-based supramolecular carriers beyond the original ocular application. Different compositions, BLMs, and therapeutic nucleic acids could be explored to tailor the physicochemical and biological properties of the system for specific applications.

Author Contributions

Conceptualization, C.L.M.; methodology, I.D., G.P., B.L.B., L.G., F.C., L.M., I.P., C.G. (Chiara Giacomelli), C.G. (Claudia Gargini), M.C.G., C.M. and C.L.M.; supervision, C.G. (Claudia Gargini), C.M. and C.L.M.; project administration, C.L.M.; writing—original draft preparation, I.D. and C.L.M. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the grant CN00000041 “National Center for Gene Therapy and Drugs based on RNA Technology” (concession number 1035 of 17 June 2022-PNRR MUR—M4C2—Investment 1.4 Call “National Centers”, financed by EU—NextGenerationEU), project code CUP I53C22000710007.

Institutional Review Board Statement

Not applicable.

Data Availability Statement

The data supporting the findings of this study are available from the corresponding author upon reasonable request. Further inquiries can be directed to the corresponding author.

Acknowledgments

During the preparation of this manuscript, the authors used OpenAI (GPT-6, ChatGPT Plus for the purpose of language and stylistic refinement. The authors have reviewed and edited the output and take full responsibility for the content of this publication.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Ma, X.; Zhao, Y. Biomedical Applications of Supramolecular Systems Based on Host–Guest Interactions. Chem. Rev. 2015, 115, 7794–7839. [Google Scholar] [CrossRef] [Scilit]
  2. Kulkarni, J.A.; Witzigmann, D.; Thomson, S.B.; Chen, S.; Leavitt, B.R.; Cullis, P.R.; van der Meel, R. The Current Landscape of Nucleic Acid Therapeutics. Nat. Nanotechnol. 2021, 16, 630–643. [Google Scholar] [CrossRef] [Scilit]
  3. Sayed, N.; Allawadhi, P.; Khurana, A.; Singh, V.; Navik, U.; Pasumarthi, S.K.; Khurana, I.; Banothu, A.K.; Weiskirchen, R.; Bharani, K.K. Gene Therapy: Comprehensive Overview and Therapeutic Applications. Life Sci. 2022, 294, 120375. [Google Scholar] [CrossRef] [Scilit]
  4. Caldera, F.; Tannous, M.; Cavalli, R.; Zanetti, M.; Trotta, F. Evolution of Cyclodextrin Nanosponges. Int. J. Pharm. 2017, 531, 470–479. [Google Scholar] [CrossRef] [Scilit]
  5. Sherje, A.P.; Dravyakar, B.R.; Kadam, D.; Jadhav, M. Cyclodextrin-Based Nanosponges: A Critical Review. Carbohydr. Polym. 2017, 173, 37–49. [Google Scholar] [CrossRef] [Scilit]
  6. Guineo-Alvarado, J.; Quilaqueo, M.; Hermosilla, J.; González, S.; Medina, C.; Rolleri, A.; Lim, L.-T.; Rubilar, M. Degree of Crosslinking in β-Cyclodextrin-Based Nanosponges and Their Effect on Piperine Encapsulation. Food Chem. 2021, 340, 128132. [Google Scholar] [CrossRef] [Scilit]
  7. Piano, I.; Polini, B.; Corsi, F.; Carpi, S.; Petrarolo, G.; Quattrini, L.; D’Agostino, I.; Gamberini, M.C.; Baraldi, C.; Chiellini, G.; et al. β-Cyclodextrin Nanosponges for the Ocular Delivery of Therapeutic Micro-RNA in a Mouse Model of Retinitis Pigmentosa: A Proof of Concept Study. Eur. J. Pharm. Biopharm. 2025, 208, 114660. [Google Scholar] [CrossRef] [Scilit]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.